Drug Des Devel Ther April 2024 PMID 38618282

The Promise of Therapeutic Psilocybin: An Evaluation of the 134 Clinical Trials, 54 Potential Indications, and 0 Marketing Approvals on ClinicalTrials.gov.

Sarah A Norring, Michael G Spigarelli

Full text PDF Download social card

Mentions

Peak: 11 in Apr 2024

across 7 sources since Apr 2024

Extended reach

60,836

potential audience

Total likes

Video views

933

Mentions per month

Apr 2024 – Mar 2025

Where it's discussed

X / Twitter11 posts
News3 articles
YouTube2 videos
Facebook2 posts
Reddit2 posts
Blogs2 articles
Bluesky1 posts

AI synopsis

What people are saying

Discussions reflect a balanced view, with posts like the exploration of psilocybin's potential as a groundbreaking treatment and mentions of clinical trial numbers indicating ongoing research efforts. The tone remains respectful and somewhat optimistic, with words like 'explore,' 'potential,' and 'promise,' which underscore a cautious enthusiasm for future developments while acknowledging current challenges.

AgreementModerate agreement

Most discussions acknowledge the potential benefits and the challenges highlighted in the publication, suggesting a general consensus on the importance of ongoing research into psilocybin’s therapeutic promise.

InterestModerate interest

Posters show moderate interest, mainly engaging with the topic as a promising but complex area, with some references to the detailed evaluations and clinical trial progress.

EngagementNeutral engagement

The engagement appears moderate, with some academic or research-oriented conversations, but limited deep or critical analysis of the article's methodology or implications.

ImpactModerate impact

People recognize the article’s significance in highlighting the slow progress and need for structured studies, framing it as an important part of the larger mental health and medical research landscape.

Abstract in brief

The text discusses the extensive research and numerous clinical trials involving psilocybin over the past twenty years, highlighting that despite promising media coverage, very few trials have progressed toward FDA approval, with only a handful reaching advanced stages.
It emphasizes that the slow progress and high costs of these trials may be hindering psilocybin's potential as a groundbreaking mental health treatment, suggesting the need for more strategic, well-designed, and efficiently executed clinical studies.
To realize psilocybin's full therapeutic promise, the article advocates for a shift from exploratory research to a more structured pharmaceutical development process, including better trial design, proper blinding, statistical rigor, and specialized expertise.

Read the full abstract

All mentions

Exploring the Therapeutic Potential of Psilocybin

In this episode, Dr. Jessica Steier and Dr. Sarah Scheinman explore psilocybin, commonly known as magic mushrooms. They discuss its historical significance, neurobiological mechanisms, and investigate its potential…

Unbiased Science · Mar 19, 2025 797 views

The Science of Psilocybin: Therapeutic Insights and Research Overview

In this episode, Dr. Jessica Steier and Dr. Sarah Scheinman explore the world of psilocybin, examining its historical significance, neurobiological mechanisms, and therapeutic potential for mental health conditions…

Unbiased Science · Mar 19, 2025 137 views

Unbiased Science

@unbiasedscipod.bsky.social · Bluesky

In this episode, Dr. Jessica Steier and Dr. Sarah Scheinman explore the complex world of psilocybin, or magic mushrooms.

Mar 19, 2025 · 11 likes · 2 shares View post →